Back
Range Cancer Therapeutics ETF Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
34
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.92
Seasonality Move:
-0.36%
Sell
18
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
21.00
Seasonality Move:
-9.84%
Sell
34
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.07. The Score for CNCR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $20.92. The Score for CRBP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.07
The current trend is moderately bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $20.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 49.96 | Sell |
Chaikin Money Flow: | -1883 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.68 - 15.58) | Sell |
Bollinger Bands (100): | (13.96 - 15.36) | Buy |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -9.22 | Sell |
Relative Strength Index (14 RSI): | 26.63 | Sell |
Chaikin Money Flow: | -808540 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.3 - 61.4) | Sell |
Bollinger Bands (100): | (39.8 - 58.48) | Sell |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.24 | Sell |
20-day SMA: | 15.16 | Sell |
50-day SMA: | 14.84 | Buy |
200-day SMA: | 14.83 | Buy |
8-day EMA: | 15.16 | Sell |
20-day EMA: | 15.14 | Sell |
50-day EMA: | 14.92 | Buy |
200-day EMA: | 14.48 | Buy |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.72 | Sell |
20-day SMA: | 43.43 | Sell |
50-day SMA: | 51.2 | Sell |
200-day SMA: | 37.41 | Sell |
8-day EMA: | 27.51 | Sell |
20-day EMA: | 38.64 | Sell |
50-day EMA: | 46.39 | Sell |
200-day EMA: | 38.73 | Sell |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.11 per share, a decrease next quarter of $0.64 per share, an increase this year of $6.97 per share, and a decrease next year of $0.83 per share.
Range Cancer Therapeutics ETF Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |